ICAD (Intracranial Atherosclerotic Disease) Pathology Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of ICAD (Intracranial Atherosclerotic Disease) Pathology in Global, including the following market information:
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at 180.2 million in 2020 and is projected to reach US$ 249 million by 2027, at a CAGR of 8.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ICAD (Intracranial Atherosclerotic Disease) Pathology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, By Type, 2020 (%)
China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, By Application, 2020 (%)
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Total ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at 180.2 million in 2020 and is projected to reach US$ 249 million by 2027, at a CAGR of 8.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ICAD (Intracranial Atherosclerotic Disease) Pathology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, By Type, 2020 (%)
- Stent
- PTA Balloon
China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, By Application, 2020 (%)
- Hospital
- Clinic
- Other
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Total ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Stryker
- Balt
- TERUMO
- MicroPort
- Acandis
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY OVERALL MARKET SIZE
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size: 2021 VS 2027
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players in Global Market
3.2 Top Global ICAD (Intracranial Atherosclerotic Disease) Pathology Companies Ranked by Revenue
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Companies
3.4 Top 3 and Top 5 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies in Global Market, by Revenue in 2020
3.5 Global Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
3.6 Tier 1, Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Players in Global Market
3.6.1 List of Global Tier 1 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies
3.6.2 List of Global Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Markets, 2021 & 2027
4.1.2 Stent
4.1.3 PTA Balloon
4.2 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
4.2.1 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
4.2.2 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
4.2.3 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
5.2.1 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
5.2.2 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
5.2.3 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2021 & 2027
6.2 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
6.2.1 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
6.2.2 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
6.2.3 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.3.2 US ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.3.3 Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.3.4 Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.4.2 Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.3 France ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.4 U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.5 Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.6 Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.7 Nordic Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.8 Benelux ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.5.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.4 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.5 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.6 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.6.2 Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.6.3 Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.7.2 Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7.3 Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7.4 Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7.5 UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Stryker
7.1.1 Stryker Corporate Summary
7.1.2 Stryker Business Overview
7.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.1.5 Stryker Key News
7.2 Balt
7.2.1 Balt Corporate Summary
7.2.2 Balt Business Overview
7.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.2.5 Balt Key News
7.3 TERUMO
7.3.1 TERUMO Corporate Summary
7.3.2 TERUMO Business Overview
7.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.3.5 TERUMO Key News
7.4 MicroPort
7.4.1 MicroPort Corporate Summary
7.4.2 MicroPort Business Overview
7.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.4.5 MicroPort Key News
7.5 Acandis
7.5.1 Acandis Corporate Summary
7.5.2 Acandis Business Overview
7.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.5.5 Acandis Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY OVERALL MARKET SIZE
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size: 2021 VS 2027
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players in Global Market
3.2 Top Global ICAD (Intracranial Atherosclerotic Disease) Pathology Companies Ranked by Revenue
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Companies
3.4 Top 3 and Top 5 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies in Global Market, by Revenue in 2020
3.5 Global Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
3.6 Tier 1, Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Players in Global Market
3.6.1 List of Global Tier 1 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies
3.6.2 List of Global Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Markets, 2021 & 2027
4.1.2 Stent
4.1.3 PTA Balloon
4.2 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
4.2.1 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
4.2.2 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
4.2.3 By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
5.2.1 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
5.2.2 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
5.2.3 By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2021 & 2027
6.2 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
6.2.1 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
6.2.2 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
6.2.3 By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.3.2 US ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.3.3 Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.3.4 Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.4.2 Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.3 France ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.4 U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.5 Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.6 Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.7 Nordic Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.4.8 Benelux ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.5.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.4 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.5 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.5.6 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.6.2 Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.6.3 Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027
6.7.2 Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7.3 Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7.4 Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
6.7.5 UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Stryker
7.1.1 Stryker Corporate Summary
7.1.2 Stryker Business Overview
7.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.1.5 Stryker Key News
7.2 Balt
7.2.1 Balt Corporate Summary
7.2.2 Balt Business Overview
7.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.2.5 Balt Key News
7.3 TERUMO
7.3.1 TERUMO Corporate Summary
7.3.2 TERUMO Business Overview
7.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.3.5 TERUMO Key News
7.4 MicroPort
7.4.1 MicroPort Corporate Summary
7.4.2 MicroPort Business Overview
7.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.4.5 MicroPort Key News
7.5 Acandis
7.5.1 Acandis Corporate Summary
7.5.2 Acandis Business Overview
7.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Major Product Offerings
7.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (2016-2021)
7.5.5 Acandis Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Opportunities & Trends in Global Market
Table 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers in Global Market
Table 3. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints in Global Market
Table 4. Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology in Global Market
Table 5. Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Companies, 2016-2021
Table 8. Global Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
Table 9. List of Global Tier 1 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 30. Stryker Corporate Summary
Table 31. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 32. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 33. Balt Corporate Summary
Table 34. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 35. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 36. TERUMO Corporate Summary
Table 37. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 38. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 39. MicroPort Corporate Summary
Table 40. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 41. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 42. Acandis Corporate Summary
Table 43. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 44. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Opportunities & Trends in Global Market
Table 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers in Global Market
Table 3. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints in Global Market
Table 4. Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology in Global Market
Table 5. Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Companies, 2016-2021
Table 8. Global Companies ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
Table 9. List of Global Tier 1 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2022-2027
Table 30. Stryker Corporate Summary
Table 31. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 32. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 33. Balt Corporate Summary
Table 34. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 35. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 36. TERUMO Corporate Summary
Table 37. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 38. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 39. MicroPort Corporate Summary
Table 40. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 41. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
Table 42. Acandis Corporate Summary
Table 43. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
Table 44. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), (2016-2021)
LIST OF FIGURES
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
Figure 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2020
Figure 8. By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 9. By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 10. By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 11. By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 12. US ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 13. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 16. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 17. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 19. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 20. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 24. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 25. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 28. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 30. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 33. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 34. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 36. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 37. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
Figure 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2020
Figure 8. By Type - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 9. By Application - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 10. By Region - Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 11. By Country - North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 12. US ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 13. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 16. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 17. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 19. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 20. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 24. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 25. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 28. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 30. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 33. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 34. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 36. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2016-2027
Figure 37. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
